ReviewOncoTargets and therapy2013

Targeted therapy for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: focus on brentuximab vedotin.

Xueyan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.